Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer

Clinical Lung Cancer

Volumn 13, Issue 5, 2012, Pages 375-384

  Hyogotani, Akira ^a   Ito, Ken Ichi ^a   Yoshida, Kazuo ^a   Izumi, Hiroto ^b   Kohno, Kimitoshi ^b   Amano, Jun ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Epidermal growth factor receptor; Lung cancer; Lung resistancerelated protein; Prognosis; Y box binding protein 1

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; LUNG RESISTANCE PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA; Y BOX BINDING PROTEIN 1;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, SMALL INTERFERING; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; VAULT RIBONUCLEOPROTEIN PARTICLES; Y-BOX-BINDING PROTEIN 1;

EID: 84865513836     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2011.11.006     Document Type: Article

References (52)

1. D.K. Didier, J. Schiffenbauer, S.L. Woulfe Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box Proc Natl Acad Sci U S A 85 1988 7322 7326
2. P.S. Holm, S. Bergmann, K. Jurchott YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter J Biol Chem 277 2002 10427 10434
3. K. Kohno, H. Izumi, T. Uchiumi The pleiotropic functions of the Y-box-binding protein, YB-1 Bioessays 25 2003 691 698
4. M. Kuwano, Y. Oda, H. Izumi The role of nuclear Y-box binding protein 1 as a global marker in drug resistance Mol Cancer Ther 3 2004 1485 1492
5. T. Ohga, T. Uchiumi, Y. Makino Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene J Biol Chem 273 1998 5997 6000
6. K. Koike, T. Uchiumi, T. Ohga Nuclear translocation of the Y-box binding protein by ultraviolet irradiation FEBS Lett 417 1997 390 394
7. T. Ohga, K. Koike, M. Ono Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light Cancer Res 56 1996 4224 4228
8. K. Asakuno, K. Kohno, T. Uchiumi Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D Biochem Biophys Res Commun 199 1994 1428 1435
9. T. Ise, G. Nagatani, T. Imamura Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen Cancer Res 59 1999 342 346
10. M. Janz, N. Harbeck, P. Dettmar Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1 Int J Cancer 97 2002 278 282
11. T. Kamura, H. Yahata, S. Amada Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma? Cancer 85 1999 2450 2454
12. K. Shibahara, K. Sugio, T. Osaki Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-small cell lung cancer Clin Cancer Res 7 2001 3151 3155
13. C. Gessner, C. Woischwill, A. Schumacher Nuclear YB-1 expression as a negative prognostic marker in Non-Small cell lung cancer Eur Respir J 23 2004 14 19
14. A. Lasham, S. Moloney, T. Hale The Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressor J Biol Chem 278 2003 35516 35523
15. A. Lasham, E. Lindridge, F. Rudert Regulation of the human fas promoter by YB-1, Puralpha and AP-1 transcription factors Gene 252 2000 1 13
16. K. Shibao, H. Takano, Y. Nakayama Enhanced coexpression of YB-1 and DNA topoisomerase II alpha genes in human colorectal carcinomas Int J Cancer 83 1999 732 737
17. R.C. Bargou, K. Jurchott, C. Wagener Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression Nat Med 3 1997 447 450
18. U. Stein, S. Bergmann, G.L. Scheffer YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene Oncogene 24 2005 3606 3618
19. R.J. Scheper, H.J. Broxterman, G.L. Scheffer Overexpression of a M(r) 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance Cancer Res 53 1993 1475 1479
20. G.L. Scheffer, P.L. Wijngaard, M.J. Flens The drug resistance-related protein LRP is the human major vault protein Nat Med 1 1995 578 582
21. M.H. Mossink, A. van Zon, R.J. Scheper Vaults: a ribonucleoprotein particle involved in drug resistance? Oncogene 22 2003 7458 7467
22. M.A. Izquierdo, A.G. van der Zee, J.B. Vermorken Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma J Natl Cancer Inst 87 1995 1230 1237
23. G. Pohl, M. Filipits, R.W. Suchomel Expression of the lung resistance protein (LRP) in primary breast cancer Anticancer Res 19 1999 5051 5055
24. H. Uozaki, H. Horiuchi, T. Ishida Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma Relationship with poor prognosis Cancer 79 1997 2336 2344
25. A. Ullrich, J. Schlessinger Signal transduction by receptors with tyrosine kinase activity Cell 61 1990 203 212
26. M. Volm, P. Drings, W. Wodrich Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas J Cancer Res Clin Oncol 119 1993 507 510
27. J. Brabender, K.D. Danenberg, R. Metzger Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer is correlated with survival Clin Cancer Res 7 2001 1850 1855
28. G. Selvaggi, S. Novello, V. Torri Epidermal growth factor receptor overexpression correlates with a poor prognosis in completely resected non-small-cell lung cancer Ann Oncol 15 2004 28 32
29. J. Wu, C. Lee, D. Yokom Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2 Cancer Res 66 2006 4872 4879
30. T. Fujita, K. Ito, H. Izumi Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel Clin Cancer Res 11 2005 8837 8844
31. J. Schneider, S. Gonzalez-Roces, M. Pollan Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy Breast Cancer Res 3 2001 183 191
32. M.A. Izquierdo, G.L. Scheffer, M.J. Flens Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors Am J Pathol 148 1996 877 887
33. M.A. Izquierdo, R.H. Shoemaker, M.J. Flens Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines Int J Cancer 65 1996 230 237
34. V.A. Kickhoefer, K.S. Rajavel, G.L. Scheffer Vaults are up-regulated in multidrug-resistant cancer cell lines J Biol Chem 273 1998 8971 8974
35. A.B. Schroeijers, G.L. Scheffer, M.J. Flens Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues Am J Pathol 152 1998 373 378
36. A.C. Siva, S. Raval-Fernandes, A.G. Stephen Up-regulation of vaults may be necessary but not sufficient for multidrug resistance Int J Cancer 92 2001 195 202
37. C.H. Versantvoort, S. Withoff, H.J. Broxterman Resistance-associated factors in human small-cell lung-carcinoma GLC4 sub-lines with increasing adriamycin resistance Int J Cancer 61 1995 375 380
38. V.N. Verovski, D.L. Van den Berge, M.M. Delvaeye Low-level doxorubicin resistance in P-glycoprotein-negative human pancreatic tumour PSN1/ADR cells implicates a brefeldin A-sensitive mechanism of drug extrusion Br J Cancer 73 1996 596 602
39. P.G. Komarov, A.A. Shtil, O. Holian Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine Oncol Res 10 1998 185 192
40. B. Wyler, Y. Shao, E. Schneider Intermittent exposure to doxorubicin in vitro selects for multifactorial non-P-glycoprotein-associated multidrug resistance in RPMI 8226 human myeloma cells Br J Haematol 97 1997 65 75
41. E. Moran, I. Cleary, A.M. Larkin Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42 Eur J Cancer 33 1997 652 660
42. W. Berger, L. Elbling, M. Micksche Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs Int J Cancer 88 2000 293 300
43. T. Harada, S. Ogura, K. Yamazaki Predictive value of expression of P53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers Cancer Sci 94 2003 394 399
44. A.M. Dingemans, J. van Ark-Otte, P. van der Valk Expression of the human major vault protein LRP in human lung cancer samples and normal lung tissues Ann Oncol 7 1996 625 630
45. C. Lange, W. Walther, H. Schwabe Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter Biochem Biophys Res Commun 278 2000 125 133
46. J.R. Grandis, J.C. Sok Signaling through the epidermal growth factor receptor during the development of malignancy Pharmacol Ther 102 2004 37 46
47. D.T. Merrick, J. Kittelson, R. Winterhalder Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer Clin Cancer Res 12 2006 2281 2288
48. N. Normanno, A. De Luca, C. Bianco Epidermal growth factor receptor (EGFR) signaling in cancer Gene 366 2006 2 16
49. N. Normanno, C. Bianco, L. Strizzi The ErbB receptors and their ligands in cancer: an overview Curr Drug Targets 6 2005 243 257
50. L.M. Sholl, B.Y. Yeap, A.J. Iafrate Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers Cancer Res 69 2009 8341 8348
51. T. Fujii, A. Kawahara, Y. Basaki Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers Cancer Res 68 2008 1504 1512
52. M. Kashihara, K. Azuma, A. Kawahara Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer J Thorac Oncol 4 2009 1066 1074